The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
Open accessAbstract
No single animal model for severe acute respiratory syndrome (SARS) reproduces all aspects of the human disease. Young inbred mice support SARS-coronavirus (SARS-CoV) replication in the respiratory tract and are available in sufficient numbers for statistical evaluation. They are relatively inexpensive and easily accessible, but their use in SARS research is limited because they do not develop illness following infection. Older (12- to 14-mo-old) BALB/c mice develop clinical illness and pneumonitis, but they can be hard to procure, and immune senescence complicates pathogenesis studies. We adapted the SARS-CoV (Urbani strain) by serial passage in the respiratory tract of young BALB/c mice. Fifteen passages resulted in a virus (MA15) that is lethal for mice following intranasal inoculation. Lethality is preceded by rapid and high titer viral replication in lungs, viremia, and dissemination of virus to extrapulmonary sites accompanied by lymphopenia, neutrophilia, and pathological changes in the lungs. Abundant viral antigen is extensively distributed in bronchial epithelial cells and alveolar pneumocytes, and necrotic cellular debris is present in airways and alveoli, with only mild and focal pneumonitis. These observations suggest that mice infected with MA15 die from an overwhelming viral infection with extensive, virally mediated destruction of pneumocytes and ciliated epithelial cells. The MA15 virus has six coding mutations associated with adaptation and increased virulence; when introduced into a recombinant SARS-CoV, these mutations result in a highly virulent and lethal virus (rMA15), duplicating the phenotype of the biologically derived MA15 virus. Intranasal inoculation with MA15 reproduces many aspects of disease seen in severe human cases of SARS. The availability of the MA15 virus will enhance the use of the mouse model for SARS because infection with MA15 causes morbidity, mortality, and pulmonary pathology. This virus will be of value as a stringent challenge in evaluation of the efficacy of vaccines and antivirals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coronavirus as a possible cause of severe acute respiratory syndrome
Peiris, J., Lai, S., Poon, L., Guan, Y., Yam, L., Lim, W., Nicholls, J., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,915
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., Ahuja, A., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,628
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C., Epstein, J. H., Wang, H., Crameri, G., Hu, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,560
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M.-H., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,474
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031
Receptor and viral determinants of SARS‐coronavirus adaptation to human ACE2
Li, W., Zhang, C., Sui, J., Kuhn, J. H., Moore, M. J., Luo, S., Wong, S., Huang, I., Xu, K., Vasilieva, N., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600640 · Cited by 988
Mechanisms and enzymes involved in SARS coronavirus genome expression
Thiel, V., Ivanov, K. A., Putics, Á., Hertzig, T., Schelle, B., Bayer, S., Weißbrich, B., Snijder, E. J., Rabenau, H., Doerr, H. W., et al. (2003) · Journal of General Virology · doi:10.1099/vir.0.19424-0 · Cited by 848
Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China
The Chinese SARS Molecular Epidemiology Consortium (2004) · Science · doi:10.1126/science.1092002 · Cited by 775
Wong, R. S. M., Wu, A., To, K. F., Lee, N., Lam, C. W. K., Wong, C. K., Chan, P. K. S., Ng, M. H. L., Yu, L. M., Hui, D. S., et al. (2003) · BMJ · doi:10.1136/bmj.326.7403.1358 · Cited by 561
Subbarao, K., McAuliffe, J., Vogel, L., Fahle, G., Fischer, S., Tatti, K., Packard, M., Shieh, W.-J., Zaki, S., & Murphy, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3572-3577.2004 · Cited by 406
Self-citationReverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus
Yount, B., Curtis, K. M., Fritz, E. A., Hensley, L. E., Jahrling, P. B., Prentice, E., Denison, M. R., Geisbert, T. W., & Baric, R. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735582100 · Cited by 376
Self-citationViral Loads in Clinical Specimens and SARS Manifestations
Hung, I. F. N., Cheng, V. C. C., Wu, A. K. L., Tang, B. S. F., Chan, K. H., Chu, C. M., Wong, M. M. L., Hui, W. T., Poon, L. L. M., Tse, D. M. W., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1009.040058 · Cited by 270
Yount, B., Roberts, R. S., Sims, A. C., Deming, D., Frieman, M. B., Sparks, J., Denison, M. R., Davis, N., & Baric, R. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14909-14922.2005 · Cited by 253
Self-citationMcAuliffe, J., Vogel, L., Roberts, A., Fahle, G., Fischer, S., Shieh, W.-J., Butler, E., Zaki, S., St. Claire, M., Murphy, B., et al. (2004) · Virology · doi:10.1016/j.virol.2004.09.030 · Cited by 208
Self-citationRoberts, A., Paddock, C., Vogel, L., Butler, E., Zaki, S., & Subbarao, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5833-5838.2005 · Cited by 198
Self-citationInitial viral load and the outcomes of SARS
Chu, C.-M. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040398 · Cited by 196
Pathogenesis of severe acute respiratory syndrome
Lau, Y. L., & Peiris, J. M. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.05.009 · Cited by 168
Fatal Severe Acute Respiratory Syndrome Is Associated with Multiorgan Involvement by Coronavirus
Farcas, G. A., Poutanen, S. M., Mazzulli, T., Willey, B. M., Butany, J., Asa, S. L., Faure, P., Akhavan, P., Low, D. E., & Kain, K. C. (2005) · The Journal of Infectious Diseases · doi:10.1086/426870 · Cited by 167
Shieh, W., Hsiao, C.-H., Paddock, C. D., Guarner, J., Goldsmith, C. S., Tatti, K. M., Packard, M. M., Mueller, L., Wu, M.-Z., Rollin, P. E., et al. (2005) · Human Pathology · doi:10.1016/j.humpath.2004.11.006 · Cited by 135
Self-citationSevere Acute Respiratory Syndrome Among Children
Leung, C., Kwan, M. Y. W., Ko, P. W., Chiu, S. S. S., Loung, P.-Y., Fong, N.-C., Lee, L.-P., Hui, Y.-W., Law, H., Wong, W. H. S., et al. (2004) · PEDIATRICS · doi:10.1542/peds.113.6.e535 · Cited by 134
Cynomolgus Macaque as an Animal Model for Severe Acute Respiratory Syndrome
Lawler, J. V., Endy, T. P., Hensley, L. E., Garrison, A. R., Fritz, E. A., Lesar, M., Baric, R. S., Kulesh, D. A., Norwood, D., Wasieloski, L. P., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030149 · Cited by 117
Self-citationIs there an ideal animal model for SARS?
Subbarao, K., & Roberts, A. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.05.007 · Cited by 104
Self-citationRoberts, A., Thomas, W. D., Guarner, J., Lamirande, E. W., Babcock, G. J., Greenough, T. C., Vogel, L., Hayes, N., Sullivan, J. L., Zaki, S. R., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/500143 · Cited by 103
Self-citationBrown, E. G. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4523-4533.1990 · Cited by 99
Smeenk, C. A., & Brown, E. G. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.530-534.1994 · Cited by 84
Severe acute respiratory distress syndrome (SARS): A critical care perspective
Manocha, S., Walley, K. R., & Russell, J. A. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000091929.51288.5f · Cited by 81
Clinical and Laboratory Features of Severe Acute Respiratory Syndrome Vis-À-Vis Onset of Fever
Liu, C., Lu, Y., Peng, M.-J., Chen, P.-J., Lin, R., Wu, C., & Kuo, H.-T. (2004) · CHEST Journal · doi:10.1378/chest.126.2.509 · Cited by 71
Brown, E. G., & Bailly, J. E. (1999) · Virus Research · doi:10.1016/s0168-1702(99)00027-1 · Cited by 62
Heise, M. T., Simpson, D. A., & Johnston, R. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4207-4213.2000 · Cited by 55
Self-citationClinical significance of hepatic derangement in severe acute respiratory syndrome
Chan, H. L. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i14.2148 · Cited by 44
Temporal Patterns of Hepatic Dysfunction and Disease Severity in Patients With SARS
Wong, W. M. (2003) · JAMA · doi:10.1001/jama.290.20.2663 · Cited by 36
Roberts, A., Wood, J., Subbarao, K., Ferguson, M., Wood, D., & Cherian, T. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.07.009 · Cited by 16
Self-citationLi, M., Li, X. H., Li, X. W., et al. (2004) · PubMed · Cited by 3
Cited by
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Coronavirus biology and replication: implications for SARS-CoV-2
V’kovski, P., Kratzel, A., Steiner, S., Stalder, H., & Thiel, V. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00468-6 · Cited by 3,197
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
COVID-19 pathophysiology: A review
Yuki, K., Fujiogi, M., & Koutsogiannaki, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108427 · Cited by 2,206
Coronaviruses post-SARS: update on replication and pathogenesis
Perlman, S., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,764
Metadata
- Authors
- Roberts, A., Deming, D., Paddock, C. D., Cheng, A., Yount, B., Vogel, L., Herman, B. D., Sheahan, T., Heise, M., Genrich, G. L., Zaki, S. R., Baric, R., & Subbarao, K.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007
- Volume
- 3
- Issue
- 1
- Pages
- e5
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W1963580683
- Cited by
- 447
- References
- 33
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.